Your browser doesn't support javascript.
loading
Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and the Merit-based Incentive Payment System.
Barbieri, John S; Miller, Jeffrey J; Nguyen, Harrison P; Forman, Howard P; Bolognia, Jean L; VanBeek, Marta J.
Affiliation
  • Barbieri JS; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: john.barbieri@uphs.upenn.edu.
  • Miller JJ; Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Nguyen HP; Yale University, New Haven, Connecticut; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
  • Forman HP; Baylor College of Medicine, Houston, Texas.
  • Bolognia JL; Yale University, New Haven, Connecticut; Department of Public Health (Health Policy), Economics, and Management, Yale University, New Haven, Connecticut.
  • VanBeek MJ; Department of Dermatology, University of Iowa (Carver) College of Medicine, Iowa City, Iowa.
J Am Acad Dermatol ; 76(6): 1206-1212, 2017 Jun.
Article in En | MEDLINE | ID: mdl-28365038
ABSTRACT
As the implementation of the Medicare Access and Children's Health Insurance Program Reauthorization Act begins, many dermatologists who provide Medicare Part B services will be subject to the reporting requirements of the Merit-based Incentive Payment System (MIPS). Clinicians subject to MIPS will receive a composite score based on performance across 4 categories quality, advancing care information, improvement activities, and cost. Depending on their overall MIPS score, clinicians will be eligible for a positive or negative payment adjustment. Quality will replace the Physician Quality Reporting System and clinicians will report on 6 measures from a list of over 250 options. Advancing care information will replace meaningful use and will assess clinicians on activities related to integration of electronic health record technology into their practice. Improvement activities will require clinicians to attest to completion of activities focused on improvements in care coordination, beneficiary engagement, and patient safety. Finally, cost will be determined automatically from Medicare claims data. In this article, we will provide a detailed review of the Medicare Access and Children's Health Insurance Program Reauthorization Act with a focus on MIPS and briefly discuss the potential implications for dermatologists.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reimbursement, Incentive / Physician Incentive Plans / Dermatology / Medicare Access and CHIP Reauthorization Act of 2015 Type of study: Prognostic_studies Limits: Child / Humans Country/Region as subject: America do norte Language: En Journal: J Am Acad Dermatol Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reimbursement, Incentive / Physician Incentive Plans / Dermatology / Medicare Access and CHIP Reauthorization Act of 2015 Type of study: Prognostic_studies Limits: Child / Humans Country/Region as subject: America do norte Language: En Journal: J Am Acad Dermatol Year: 2017 Document type: Article